Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Patients will receive intravenous(i.v.) magnesium sulphate: Before induction of Anaesthesia patients will receive magnesium sulphate in dose of 20mg/kg over 15min by i.v. route and 20mg
Sponsors
Mahatma Gandhi medical College and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Patients fulfilling American society of Anaesthesiologists grade 1,2 Patients aged between 18 years to 65 years posted for major spine surgeries
Exclusion criteria
Exclusion criteria: Patients allergic to local anaesthetics Patients on opioids for chronic pain Patients who refused to be a part of the study Patients with impared hepatic and renal function Patients on calcium channel blockers and magnesium Patients posted for surgeries with duration greater than 5hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will evaluate the effectiveness of intraoperative intravenous magnesium sulphate on post operative pain in major spine surgeries by comparing NRS scale in post operative period in study groupsTimepoint: The study will evaluate the effectiveness of intraoperative intravenous magnesium sulphate on post operative pain in major spine surgeries by comparing NRS scale in post operative period in study groups at 2hours , 4hours ,6hours,12hours,24hours after emergence from Anaesthesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| To note post operative nausea vomiting and adverse effects if anyTimepoint: Post operative nausea vomiting and adverse effects will be noted at 2hors,4hours,6hours,12hours,24 hours after emergence from Anaesthesia. | — |
Countries
India
Contacts
Public ContactDr Mangilal Deganwa
Mahatma Gandhi medical College and hospital
Outcome results
None listed